medical-device-investing Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017
pharmaceutical-investing Final Patient Completes Treatment in First Leg of OncBioMune's Clinical Trial
3d-printing-investing Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
3d-printing-investing Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
Scripps Research Institute Spin-off iGenomX Launches with Transformational New Library Construction Technology for DNA Sequencing
OncBioMune Enters Joint Venture, Preparation for Phase 2 Trial of Novel Cancer Vaccine for Prostate Cancer Underway
